These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33048424)

  • 1. SARS-CoV-2 viral dynamics in immunocompromised patients.
    Caillard S; Benotmane I; Gautier Vargas G; Perrin P; Fafi-Kremer S
    Am J Transplant; 2021 Apr; 21(4):1667-1669. PubMed ID: 33048424
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19.
    Roedl K; Heidenreich S; Pfefferle S; Jarczak D; Urbanowicz TT; Nörz D; Aepfelbacher M; Kröger N; Kluge S; Lütgehetmann M; Christopeit M; Wichmann D
    Am J Respir Crit Care Med; 2021 Jan; 203(2):242-245. PubMed ID: 33253054
    [No Abstract]   [Full Text] [Related]  

  • 3. Where did 'weird' Omicron come from?
    Kupferschmidt K
    Science; 2021 Dec; 374(6572):1179. PubMed ID: 34855502
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous manifestations of COVID-19: A case report and a new finding from Egypt.
    Farouk S; Sadek A
    Dermatol Ther; 2020 Nov; 33(6):e14038. PubMed ID: 32691948
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
    Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
    J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
    Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
    mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Infection in Kidney Transplant Recipients in Italy: Management Issues in a Kidney Transplant Center.
    Sarno G; Russo E; Ferrara A; Cerbone V; Villa R; De Rosa P
    Exp Clin Transplant; 2021 Mar; 19(3):284-286. PubMed ID: 33455573
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir.
    Camprubí D; Gaya A; Marcos MA; Martí-Soler H; Soriano A; Mosquera MDM; Oliver A; Santos M; Muñoz J; García-Vidal C
    Int J Infect Dis; 2021 Mar; 104():379-381. PubMed ID: 33359065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in Immunocompromised Patients: A Systematic Review.
    Stainer A; Amati F; Suigo G; Simonetta E; Gramegna A; Voza A; Aliberti S
    Semin Respir Crit Care Med; 2021 Dec; 42(6):839-858. PubMed ID: 34918325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/SARS-CoV-2 coinfection: A global perspective.
    Kanwugu ON; Adadi P
    J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Variants in Patients with Immunosuppression.
    Corey L; Beyrer C; Cohen MS; Michael NL; Bedford T; Rolland M
    N Engl J Med; 2021 Aug; 385(6):562-566. PubMed ID: 34347959
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy.
    Patel RH; Acharya A; Mohan M; Byrareddy SN
    J Med Virol; 2021 Feb; 93(2):641-643. PubMed ID: 32779740
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunocompromised Patients With COVID-19 Receive Interferon Gamma.
    Abbasi J
    JAMA; 2021 Dec; 326(22):2250. PubMed ID: 34905045
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab.
    Lenti MV; Gregorini M; Borrelli de Andreis F; Rampino T; D'Ambrosio G; Verga L; Vanoli A; Mengoli C; Ravetta V; Paulli M; Di Sabatino A
    J Clin Pathol; 2021 Aug; 74(8):540-542. PubMed ID: 32820044
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.
    Ray A; Debata I; Agrawal I; Panda M
    Dermatol Ther; 2020 Nov; 33(6):e14036. PubMed ID: 32697015
    [No Abstract]   [Full Text] [Related]  

  • 16. Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection.
    Wang H; Yuan Y; Xiao M; Chen L; Zhao Y; Haiwei Zhang ; Long P; Zhou Y; Xu X; Lei Y; Bihao Wu ; Diao T; Cai H; Liu L; Shao Z; Wang J; Bai Y; Wang K; Peng M; Liu L; Han S; Mei F; Cai K; Lei Y; Pan A; Wang C; Gong R; Li X; Wu T
    Cell Mol Immunol; 2021 Jul; 18(7):1832-1834. PubMed ID: 34099890
    [No Abstract]   [Full Text] [Related]  

  • 17. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.
    Livanos AE; Jha D; Cossarini F; Gonzalez-Reiche AS; Tokuyama M; Aydillo T; Parigi TL; Ladinsky MS; Ramos I; Dunleavy K; Lee B; Dixon RE; Chen ST; Martinez-Delgado G; Nagula S; Bruce EA; Ko HM; Glicksberg BS; Nadkarni G; Pujadas E; Reidy J; Naymagon S; Grinspan A; Ahmad J; Tankelevich M; Bram Y; Gordon R; Sharma K; Houldsworth J; Britton GJ; Chen-Liaw A; Spindler MP; Plitt T; Wang P; Cerutti A; Faith JJ; Colombel JF; Kenigsberg E; Argmann C; Merad M; Gnjatic S; Harpaz N; Danese S; Cordon-Cardo C; Rahman A; Schwartz RE; Kumta NA; Aghemo A; Bjorkman PJ; Petralia F; van Bakel H; Garcia-Sastre A; Mehandru S
    Gastroenterology; 2021 Jun; 160(7):2435-2450.e34. PubMed ID: 33676971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Hyperaesthesia in SARS-CoV-2 Infection: Rare but not Unique Clinical Manifestation.
    Krajewski PK; Maj J; Szepietowski JC
    Acta Derm Venereol; 2021 Jan; 101(1):adv00366. PubMed ID: 33320278
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
    Weigang S; Fuchs J; Zimmer G; Schnepf D; Kern L; Beer J; Luxenburger H; Ankerhold J; Falcone V; Kemming J; Hofmann M; Thimme R; Neumann-Haefelin C; Ulferts S; Grosse R; Hornuss D; Tanriver Y; Rieg S; Wagner D; Huzly D; Schwemmle M; Panning M; Kochs G
    Nat Commun; 2021 Nov; 12(1):6405. PubMed ID: 34737266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.